Swiss expect approval of Covid-19 booster by end of October
Switzerland’s medical regulator has said it expects to give the green light for the third Covid-19 jab in a matter of weeks. This comes amid growing concerns about a rising number of infections and deaths among vaccinated individuals.
In an interview on Swiss public television, SRFExternal link, on Monday, Swissmedic’s head of regulatory affairs Claus Bolte indicated that the agency is still investigating the need for a third, or so-called booster, shot. In particular, the question of who should receive them and when they should be administered still needed to be addressed.
Bolte said that approval is possible in a matter of weeks “if the relevant companies cooperate”. The exact timing depends on how long it takes for companies to “answer our questions in such a way that we can also extend the approval”. Up to now the agency has hesitated to give a concrete timeframe for approval of boosters.
Various experts reacted to the announcement, including Rudolf Hauri, president of the Association of Swiss Cantonal Physicians, who told the German-language paper Tages-AnzeigerExternal linkthat while he hopes a third shot will be approved soon, authorities should not be put under pressure to do so quickly. They should “decide only on the basis of the available data and facts”.
Christoph Berger, president of the Federal Commission for Vaccinations, weighed in, telling the Swiss daily Blick that the general population “certainly doesn’t need a booster this year” as there is no indication that protection from mRNA vaccines is waning for this group. He had previously predicted booster approval by the end of the year.
Breakthrough rate
Some countries such as the United States, Israel and several European countries have already started administering booster shots among the general population.
The news comes amid a rising number of so-called “breakthrough” infections and deaths of vaccinated individuals.
The Federal Office of Public Health has reported that the breakthrough rate is three times higher for the Pfizer/BioNTech vaccine than that of Moderna. The former was, however, the first to be administered in Switzerland at the end of 2020.
Some 40 people fully vaccinated with Pfizer and 12 people vaccinated with Moderna have died in Switzerland since September 1. In the same period, 144 unvaccinated people died of Covid-19.
Overall, more than 10,000 people have died in Switzerland in connection with Covid.19.
One less vaccine
On Tuesday, Swissmedic announced that German biotech company CureVac had withdrawn its application for approval of its Covid-19 vaccine candidate. This comes after the company said it was abandoning development of its first generation vaccine candidate. Early results had shown efficacy levels of less than 50%, which is much lower than the Pfizer/BioNtech and Moderna vaccines.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Swiss climate activists block vehicles near Gotthard tunnel
This content was published on
Around ten climate activists briefly blocked the A2 motorway near the northern entrance of the Gotthard tunnel on Thursday.
Watches belonging to Michael Schumacher up for auction
This content was published on
Schumacher's family is auctioning off eight rare watches from his collection in Geneva. The Christie's auction will take place on Monday.
Joya Marleen and Baschi named best solo acts at Swiss Music Awards
This content was published on
St. Gallen singer Joya Marleen and Baschi from Basel were named artists of the year at the Swiss Music Awards 2024 on Wednesday night.
Swiss authorities announce cost-cutting in asylum sector
This content was published on
The government notably wants to improve integration into the labour force, particularly for people with protection status S.
Various leaders confirm participation at Ukraine peace conference
This content was published on
The presidents of Poland, Finland, and Latvia and the prime ministers of Spain and Belgium will be at the Swiss-hosted talks in mid-June.
This content was published on
In the winter season up to April 2024, railway and cable car operators ferried 3% more visitors compared to the previous winter, and 5% more than the five-year average.
Rhine flooding: Swiss to invest CHF1 billion with Austria
This content was published on
As part of an international agreement with Austria, the Swiss government wants to pump CHF1 billion ($1.1 billion) into flood protection measures along the Rhine over the next three decades.
Swiss government proposes CHF10 million UNRWA donation
This content was published on
After months of debate, Switzerland plans to give CHF10 million ($11 million) to the UN agency this year, rather than the CHF20 million initially foreseen.
Coronavirus: Wealthy Switzerland is suffering from vaccine fatigue
This content was published on
Enough doses, but fewer people willing to get vaccinated – many rich countries like Switzerland are seeing a stagnation in vaccination rates.
This content was published on
The president of the Federal Vaccination Commission predicts it should be available “in the November, December, January range”.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.